About

Alercell, Inc. is a biotech company based in Bozeman, Montana, focused on developing next-generation diagnostics for oncology. Its flagship technology, the Deep Leukemic Cloud Platform (DLCP), leverages AI and real-world patient data to deliver scalable solutions for early leukemia detection and monitoring. Alercell has filed a group of patents to protect these innovations as it advances toward commercialization. Learn more at www.alercell.com and www.Lenadx.com